Recent Research on Nanostructured Biomedicine: Clinical Potential and Safety
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 22018
Special Issue Editor
Special Issue Information
Dear Colleagues,
In the last decade, nanotechnology has been described as a revolutionary approach for many applications, including Biomedicine. In this field, it is today more and more mandatory to develop engineered nanomaterials able to face specific medical needs and that can represent ideal candidates for clinical translation due to the combination of efficacy and safety.
The present Special Issue aims to collect original studies reporting the development and the biological efficacy of nanoparticles of different origin and structure for the treatment and/or diagnosis of different pathologies. The proposed nanosystems can be inorganic, organic or composite materials, properly engineered for the optimization of diagnosis, drug delivery, photothermal/photodynamic therapy, gene and cell therapy, tissue engineering, etc. In vitro or in vivo assays, or alternative approaches on developing organisms will be taken into account as suitable tools for the biological validation of the nanosystems, such as for the evaluation of their toxicological impact. A multidisciplinary approach, using standard and innovative experimental approaches will be encouraged to determine the efficiency and the safety of the proposed nanodevices.
Dr. Luisa Fiandra
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nanomedicine
- Theranostics
- Nanodrugs
- in vitro/in vivo Assays
- Alternative Animal Models
- Nanotoxicology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.